NovoCure Ltd
NVCR
17 insider filings · Latest: Apr 28, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | Mar 5 9:33 PM | Nicolas LeupinFormer Chief Medical Officer | Sale | 1,100 | $13.31 | $14.6K | 102,979(D) | View → |
| Mar 4, 2026 | Mar 5 9:32 PM | Uri WeinbergChf Medical and Innovation Ofr | Sale | 6,412 | $13.31 | $85.3K | 267,190(D) | View → |
| Mar 4, 2026 | Mar 5 9:31 PM | Christoph BrackmannChief Financial Officer | Sale | 6,412 | $13.31 | $85.3K | 182,842(D) | View → |
| Mar 4, 2026 | Mar 5 9:31 PM | Frank X LeonardChief Executive Officer | Sale | 5,607 | $13.31 | $74.6K | 493,793(D) | View → |
| Mar 5, 2026 | Mar 5 9:31 PM | Mukund ParavasthuChief Operating Officer | Sale | 43,246 | $13.77 | $595.7K | 72,832(D) | View → |
| Mar 4, 2026 | Mar 5 9:31 PM | Mukund ParavasthuChief Operating Officer | Sale | 5,377 | $13.31 | $71.5K | 116,078(D) | View → |
| Mar 4, 2026 | Mar 5 9:31 PM | Michal Nath PuriChief Human Resources Officer | Sale | 1,100 | $13.31 | $14.6K | 201,322(D) | View → |
| Mar 3, 2026 | Mar 5 9:30 PM | William F DoyleDirector, Executive Chairman | Sale | 71,887 | $12.98 | $932.9K | 328,397(D) | View → |
| Mar 5, 2026 | Mar 5 9:06 PM | MUKUND PARAVASTHU | Proposed Sale | 43,246 | $13.77 | $595.7K | — | View → |
| Mar 4, 2026 | Mar 4 10:54 PM | CHRISTOPH BRACKMANN | Proposed Sale | 6,412 | $13.31 | $85.3K | — | View → |
| Mar 4, 2026 | Mar 4 10:53 PM | URI WEINBERG | Proposed Sale | 6,412 | $13.31 | $85.3K | — | View → |
| Mar 4, 2026 | Mar 4 10:42 PM | MUKUND PARAVASTHU | Proposed Sale | 5,377 | $13.31 | $71.5K | — | View → |
| Mar 4, 2026 | Mar 4 10:13 PM | FRANCIS LEONARD | Proposed Sale | 5,607 | $13.31 | $74.6K | — | View → |
| Mar 3, 2026 | Mar 3 10:01 PM | WILLIAM DOYLE | Proposed Sale | 71,887 | $12.98 | $932.9K | — | View → |
| Mar 2, 2026 | Mar 3 9:11 PM | Uri WeinbergChf Medical and Innovation Ofr | Sale | 3,272 | $13.33 | $43.6K | 223,477(D) | View → |
| Feb 27, 2026 | Mar 3 9:11 PM | Uri WeinbergChf Medical and Innovation Ofr | Sale | 7,461 | $13.84 | $103.3K | 213,757(D) | View → |
| Feb 27, 2026 | Mar 3 9:10 PM | Michal Nath PuriChief Human Resources Officer | Sale | 1,441 | $13.66 | $19.7K | 162,322(D) | View → |
| Mar 2, 2026 | Mar 3 9:10 PM | Mukund ParavasthuChief Operating Officer | Sale | 408 | $13.49 | $5.5K | 76,343(D) | View → |
| Feb 27, 2026 | Mar 3 9:10 PM | Mukund ParavasthuChief Operating Officer | Sale | 1,555 | $13.66 | $21.2K | 76,751(D) | View → |
| Feb 27, 2026 | Mar 3 9:09 PM | Nicolas LeupinFormer Chief Medical Officer | Sale | 1,029 | $13.66 | $14.1K | 104,079(D) | View → |
Page 1 of 3
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | Apr 28 8:27 PM | Anthony W VernonDirector | Option Exercise | 21,500 | $11.39 | 0(D) | View → |
| Mar 3, 2026 | Mar 5 9:32 PM | Arye Barak BenGeneral Counsel | Grant/Award | 73,340 | $13.30 | 73,340(D) | View → |
| Mar 3, 2026 | Mar 5 9:32 PM | Uri WeinbergChf Medical and Innovation Ofr | Grant/Award | 73,340 | $13.30 | 73,340(D) | View → |
| Mar 3, 2026 | Mar 5 9:31 PM | Christoph BrackmannChief Financial Officer | Grant/Award | 80,674 | $13.30 | 80,674(D) | View → |
| Mar 3, 2026 | Mar 5 9:31 PM | Frank X LeonardChief Executive Officer | Grant/Award | 216,388 | $13.30 | 216,388(D) | View → |
| Mar 3, 2026 | Mar 5 9:31 PM | Mukund ParavasthuChief Operating Officer | Grant/Award | 66,006 | $13.30 | 66,006(D) | View → |
| Mar 3, 2026 | Mar 5 9:31 PM | Michal Nath PuriChief Human Resources Officer | Grant/Award | 58,672 | $13.30 | 58,672(D) | View → |
| Mar 3, 2026 | Mar 5 9:30 PM | William F DoyleDirector, Executive Chairman | Grant/Award | 288,517 | $13.30 | 288,517(D) | View → |